1. |
邓家栋,杨崇礼,杨天楹,主编.邓家栋临床血液学.上海:上海科学技术出版社,2001: 1655- 1656.
|
2. |
Zaia JA. Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone Marrow Transplant, 2002, 29: 633-638.
|
3. |
Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol, 1997, 97: 855-864.
|
4. |
Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med, 2002, 78: 257-262.
|
5. |
Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant, 2001, 28: 425-434.
|
6. |
Bourke SJ. Interstitial lung disease: Progress and Problems. Postgrad Med J, 2006, 82: 494- 499.
|
7. |
Krause H, Hebart H, Jahn G,et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant, 1997,19: 1111-1116.
|
8. |
黄晓军,陆道培.骨髓移植后CMV间质性肺炎.国外医学输血及血液学分册,1996,19:282-284.
|
9. |
Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation.J Infect Dis,1986,153: 478-488.
|
10. |
Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant, 1994, 14 (Suppl 4): S19-S28.
|
11. |
King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med, 2005, 172: 268-279.
|
12. |
Ljungman P, De Bock R, Cordonnier C, et al. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant, 1993, 12: 399-403.
|
13. |
丁昊炜, 任汉云, 郭乃榄, 等. 造血干细胞移植患者巨细胞病毒感染危险因素和疗效分析. 北京大学学报(医学版), 2003, 35: 596-599.
|